VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading EV charging operator, is announcing the release of its unaudited financial results for the three months ended June 30, 2026, and related management discussion and analysis. All dollar figures are in Canadian Dollars, unless otherwise stated. “Fiscal 2027 began with a continued focus on higher-margin Level 2 charging deployments that improve recurring revenue growth and overall revenue durability. While fiscal Q1 presented challenges with revenue falling year-over-year and our operating loss increase, we have made investments this quarter to improve the long-term sustainability of our business. The shift in our revenue mix was evident in the growth of subscription and...

VANCOUVER, British Columbia, Aug. 28, 2026 (GLOBE NEWSWIRE) — Central 1 Credit Union (Central 1) today reported second quarter financial results and provided an update on performance across its core businesses. “Our performance in the first half of 2026 reflects steady advancement of our strategic priorities, along with growth in our core business, against a backdrop of ongoing market volatility,” said Sheila Vokey, Central 1’s CEO. “In the second quarter, we continued our prudent approach, delivering quarterly profitability coupled with a disciplined increase in our credit provisions to protect against evolving conditions.” Second quarter 2026 compared with second quarter 2025:Net income of $13.1 million, compared with $21.4 million Adjusted net income1 of $13.0 million, compared with $22.3 million Pre-provision, pre-tax...

Admiral Markets AS unaudited interim report for the first 6 months of 2026 In the first half of 2026, Admiral Markets AS completed the restructuring of its business, exiting direct client servicing and continuing solely as an intra-group liquidity provider for the Admirals Group following the voluntary revocation of its investment firm license in Estonia.Net trading income was EUR 2.2 million (6M 2025: EUR 4.1 million). Net loss was EUR -2.6 million (6M 2025: EUR -3.5 million).All client relationships of Admiral Markets AS were terminated in January 2026, with former clients offered continued service through Admirals Europe Ltd, the Admirals Group’s Cyprus-licensed investment firm. Acting on its own initiative, Admiral Markets AS applied to the Estonian Financial Supervision and Resolution Authority to withdraw its investment firm...

According to the current regulations, Sword Group announces that its 2026 interim Financial Report has been made available to the public.It was sent to the Commission de Surveillance du Secteur Financier (CSSF) and was also filed with the Luxembourg Stock Exchange.It can be viewed and downloaded on the website of the company: 2026 INTERIM FINANCIAL REPORT About Sword GroupSword has 3,900+ IT/Digital specialists active in 50+ countries to accompany you in the growth of your organisation in the digital age.As a leader in technological and digital transformation, Sword has a solid reputation in complex IT & business project management.Sword optimises your processes and enhances your data.AttachmentSwordGroup_Availability of the 2026 Interim Financial Report_V28082026

Regulated information, Leuven, 28 August 2026 (17.40 CEST) KBC Ancora closes financial year 2025/2026 with a profit of EUR 389.4 million Confirmation of dividend policy, with future use of undistributed funds for the repurchase of own shares, after repayment of financial debts For the financial year 2025/2026, KBC Ancora recorded a profit of EUR 389.4 million, or EUR 5.06 per share. In the previous financial year, KBC Ancora recorded a profit of EUR 315.4 million.The result for the last six months of the financial year was EUR 315.0 million, or EUR 4.09 per share. On June 4, 2026, KBC Ancora distributed a gross interim dividend of EUR 4.32 per share and, as previously announced, will not pay a final dividend. The Board of Directors of Almancora Société de gestion, statutory director of KBC Ancora, hereby presents the annual figures for...

The main business activity of Trigon Property Development AS is real estate development. As at 30.06.2026, AS Trigon Property Development owned one development project with an area of 13.2 hectares in the City of Pärnu, Estonia. A commercial, industrial and logistics park is planned on this area. The Company’s objective is to find companies willing to bring their business activities (industry, logistics) to the development project area of AS Trigon Property Development in Pärnu, which would add value to the land plots owned by the Company. As the main purpose of the company is to sell existing land plots, investment property was recognized as inventories. Condensed statement of financial position as of 30 June 2026 delivered by the present announcement completely reflects the assets, liabilities and equity capital of AS Trigon Property...

SHENZHEN, China, Aug. 28, 2026 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or “the Company”), a customer-oriented property technology company in China, today announced its unaudited financial results for the six months ended June 30, 2026. First Half 2026 Financial HighlightsRevenue for the six months ended June 30, 2026 decreased by 43.1% to RMB115.7 million (US$17.1 million) from RMB203.4 million for the same period of 2025. Net loss for the six months ended June 30, 2026 was RMB34.5 million (US$5.1 million), compared to net loss of RMB39.2 million for the same period of 2025. Non-GAAP net loss1 for the six months ended June 30, 2026 was RMB34.5 million (US$5.1 million), compared to non-GAAP net loss of RMB39.2 million for the same period of 2025.First Half 2026 Operating HighlightsTotal closed-loop...

TORONTO, Aug. 28, 2026 (GLOBE NEWSWIRE) — Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQX: GGGOF) is pleased to announce the release of its financial and operating results for the three and six months ended June 30, 2026. A copy of the unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2026, prepared in accordance with International Financial Reporting Standards, and the corresponding management’s discussion and analysis (the “MD&A”), are available under the Company’s profile on www.sedarplus.ca. All references to “$” in this press release refer to United States dollars. Second Quarter 2026 (“Q2 2026”) Highlights:mined 40,159 tonnes of ore from its Galaxy and Princeton ore bodies at an average grade of 2.98 grammes per tonne (g/t) compared to 44,042...

Six-month revenue reaches $21.5 million as the addition of 123 Investments Limited expands Globaltech’s operating base RENO, Nev., Aug. 28, 2026 (GLOBE NEWSWIRE) — Globaltech Corporation (OTCQB: GLTK) (“Globaltech” or the “Company”), a publicly-traded technology platform company focused on building and scaling AI and Big Data businesses within real operating environments across telecommunications, retail commerce, financial, enterprise, and sports technology, today discussed its financial results for the three and six months ended June 30, 2026. The Company’s common stock is temporarily trading under the symbol “GLTKD” following the effectiveness of its previously announced 1-for-3 reverse stock split. The trading symbol is expected to revert to “GLTK” following a period of 20 trading days. Results include 123 Investments Limited,...

SAN DIEGO, Aug. 28, 2026 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced its financial results for the fiscal year ended June 30, 2026, and provided a corporate update on its progress. “Fiscal year 2026 was a transformative year for iBio, most importantly marked by our transition to a clinical-stage company with the initiation of the Phase 1 clinical trial of IBIO-600, a potentially best-in-class, long-acting anti-myostatin monoclonal antibody designed to preserve muscle and improve body composition,” said Martin Brenner, Ph.D., DVM, Chief Executive Officer and Chief Scientific Officer of iBio. “Additional highlights came from our IBIO-610 program, where we presented preclinical...